• 1
    Spickett GP, Farrant J, North ME, Zhang JG, Morgan L, Webster AD. Common variable immunodeficiency: how many diseases? Immunol Today 1997; 18: 3258.
  • 2
    Kinlen LJ, Webster ADB, Bird AG et al. Prospective study of cancer in patients with hypogammaglobulinaemia. Lancet 1985; 1: 2636.
  • 3
    Mellemkjær L, Hammarström L, Andersen V et al. Cancer risk among patients with IgA deficiency or common variable immunodeficiency and their relatives: a combined Danish and Swedish study. Clin Exp Immunol 2002; 130: 495500.
  • 4
    Cunningham-Rundles C, Siegal FP, Cunningham-Rundles S, Lieberman P. Incidence of cancer in 98 patients with common varied immunodeficiency. J Clin Immunol 1987; 7: 2949.
  • 5
    Cottier H, Kraft R, Meister F. Primary immunodeficiency syndromes and their manifestation in lymph nodes. Curr Top Pathol 1991; 84: 81155.
  • 6
    Spickett GP, Matamoras N, Farrant J. Lymphocyte surface phenotype in common variable immunodeficiency. Dis Markers 1992; 10: 6780.
  • 7
    Snover DC, Filipovich AH, Dehner LP, Drivit W. Pseudolymphoma: a case associated with primary immunodeficiency and polyglandular failure syndrome. Arch Pathol Laboratory Med 1981; 105: 469.
  • 8
    Laszewski MJ, Kemp JD, Goeken JA, Mitros FA, Platz CE, Dick FR. Clonal immunoglobulin gene rearrangement in nodular lymphoid hyperplasia of the gastrointestinal tract associated with common variable immunodeficiency. Am J Clin Pathol 1990; 94: 33843.
  • 9
    Spickett GP, Askew T, Chapel HM. Management of primary antibody deficiency by consultant immunologists in the United Kingdom: a paradigm for other rare diseases. Qual Health Care 1995; 4: 2638.
  • 10
    Spickett GP, Chapel HM. Summary of antibody deficiency audit, 1993–96. CPD Bull Immunol Allergy 2000; 1: 5861.
  • 11
    Conley ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol 1999; 93: 1907.
  • 12
    Harris NL, Jaffe ES, Stein H et al. A revised European–American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 136192.
  • 13
    Smith JL, Hodges E, Quin CT, McCarthy KP, Wright DH. Frequent T and B cell oligoclones in histologically and immunophenotypically characterized angioimmunoblastic lymphadenopathy. Am J Pathol 2000; 156: 6619.
  • 14
    McCarthy KP, Sloane JP, Kabarowski JH, Matutes E, Wiedemann LM. A simplified method of detection of clonal rearrangements of the T cell receptor-gamma chain gene. Diagn Mol Pathol 1992; 1: 1739.
  • 15
    McCarthy KP, Sloane JP, Kabarowski JH, Matutes E, Wiedemann LM. The rapid detection of clonal T-cell proliferations in patients with lymphoid disorders. Am J Pathol 1991; 138: 8218.
  • 16
    Diss TC, Peng H, Wotherspoon AC, Isaacson PG, Pan L. Detection of monoclonality in low-grade B-cell lymphomas using the polymerase chain reaction is dependent on primer selection and lymphoma type. J Pathol 1993; 169: 2915.
  • 17
    Potter MN, Steward CG, Oakhill A. The significance of detection of minimal residual disease in childhood acute lymphoblastic leukaemia. Br J Haematol 1993; 83: 4128.
  • 18
    Cunningham-Rundles C, Bodian C. Common variable immunodeficiency. Clinical and immunological features of 248 patients. Clin Immunol 1999; 92: 3448.
  • 19
    Cunningham-Rundles C. Clinical and immunologic analyses of 103 patients with common variable immunodeficiency. J Clin Immunol 1989; 9: 2233.
  • 20
    Cunningham-Rundles C, Lieberman P, Hellman G, Chaganti RS. Non-Hodgkin lymphoma in common variable immunodeficiency. Am J Hematol 1991; 37: 6974.
  • 21
    Sander CA, Medeiros LJ, Weiss LM, Yano T, Sneller MC, Jaffe ES. Lymphoproliferative lesions in patients with common variable immunodeficiency syndrome. Am J Surg Pathol 1992; 16: 117082.
  • 22
    Frizzera G, Rosai J, Dehner LP, Spector BD, Kersey JH. Lymphoreticular disorders in primary immunodeficiencies: new findings based on an up-to-date histologic classification of 35 cases. Cancer 1980; 42: 6929.
  • 23
    Filipovich AH, Heinitz KJ, Robison LL, Frizzera G. The Immunodeficiency Cancer Registry. A research resource. Am J Paediatr Hematol Oncol 1987; 9: 1834.
  • 24
    Canioni D, Jabado N, MacIntyre E, Patcy N, Emile JF, Brousse N. Lymphoproliferative disorders in children with primary immunodeficiencies: immunological status may be more predictive of the outcome than other criteria. Histopathology 2001; 38: 14659.
  • 25
    Mantegazza R, Andreetta F, Bernasconi P et al. Analysis of T cell receptor repertoire of muscle infiltrating T lymphocytes in polymyositis. Restricted V alpha/beta rearrangements may indicate antigen-driven selection. J Clin Invest 1993; 91: 28806.
  • 26
    Massengill SF, Goodenow MM, Sleasman JW. SLE nephritis is associated with an oligoclonal expansion of intrarenal T cells. Am J Kidney Dis 1998; 31: 41826.
  • 27
    Rieux-Laucat F, Bahadoran P, Brousse N et al. Highly restricted human T cell repertoire in peripheral blood and tissue-infiltrating lymphocytes in Omenn's syndrome. J Clin Invest 1998; 102: 31221.
  • 28
    Signorini S, Imberti L, Pirovano S et al. Intrathymic restriction and peripheral expansion of the T-cell repertoire in Omenn syndrome. Blood 1999; 94: 346878.